Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals

Zhi Hao Li, Wen Fang Zhong, Yue Bin Lv, Virginia Byers Kraus, Xiang Gao, Pei Liang Chen, Qing Mei Huang, Jin Dong Ni, Xiao Ming Shi, Chen Mao, Xian Bo Wu

Research output: Contribution to journalArticle

Abstract

Background: The association of high-sensitivity C-reactive protein (hsCRP) with mortality is controversial. We aimed to investigate the associations of hsCRP concentrations with the risks of all-cause and cause-specific mortality and identify potential modifying factors affecting these associations among middle-aged and elderly individuals. Methods: This community-based prospective cohort study included 14,220 participants aged 50+ years (mean age: 64.9 years) from the Health and Retirement Study. Cox proportional hazard models were employed to estimate the associations between the hsCRP concentrations and the risk of all-cause and cause-specific mortality with adjustment for sociodemographic and lifestyle factors, self-reported medical history, and other potential confounders. Results: In total, 1730 all-cause deaths were recorded, including 725 cardiovascular- and 417 cancer-related deaths, after an 80,572 person-year follow-up (median: 6.4 years; range: 3.6-8.1 years). The comparisons of the groups with the highest (quartile 4) and lowest (quartile 1) hsCRP concentrations revealed that the adjusted hazard ratios and 95% confidence intervals were 1.50 (1.31-1.72) for all-cause mortality, 1.44 (1.13-1.82) for cardiovascular mortality, and 1.67 (1.23-2.26) for cancer mortality. The associations between high hsCRP concentrations and the risks of all-cause, cardiovascular, and cancer mortality were similar in the men and women (P for interaction > 0.05). Conclusions: Among middle-aged and older individuals, elevated hsCRP concentration could increase the risk of all-cause, cardiovascular, and cancer mortality in men and women.

Original languageEnglish (US)
Article number28
JournalImmunity and Ageing
Volume16
Issue number1
DOIs
StatePublished - Nov 5 2019

Fingerprint

C-Reactive Protein
Mortality
Neoplasms
Retirement
Proportional Hazards Models
Life Style
Cause of Death
Cohort Studies
Prospective Studies
Confidence Intervals
Health

All Science Journal Classification (ASJC) codes

  • Immunology
  • Aging

Cite this

Li, Zhi Hao ; Zhong, Wen Fang ; Lv, Yue Bin ; Kraus, Virginia Byers ; Gao, Xiang ; Chen, Pei Liang ; Huang, Qing Mei ; Ni, Jin Dong ; Shi, Xiao Ming ; Mao, Chen ; Wu, Xian Bo. / Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals. In: Immunity and Ageing. 2019 ; Vol. 16, No. 1.
@article{ec9d241ad7b64d45b92e3a4618dff752,
title = "Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals",
abstract = "Background: The association of high-sensitivity C-reactive protein (hsCRP) with mortality is controversial. We aimed to investigate the associations of hsCRP concentrations with the risks of all-cause and cause-specific mortality and identify potential modifying factors affecting these associations among middle-aged and elderly individuals. Methods: This community-based prospective cohort study included 14,220 participants aged 50+ years (mean age: 64.9 years) from the Health and Retirement Study. Cox proportional hazard models were employed to estimate the associations between the hsCRP concentrations and the risk of all-cause and cause-specific mortality with adjustment for sociodemographic and lifestyle factors, self-reported medical history, and other potential confounders. Results: In total, 1730 all-cause deaths were recorded, including 725 cardiovascular- and 417 cancer-related deaths, after an 80,572 person-year follow-up (median: 6.4 years; range: 3.6-8.1 years). The comparisons of the groups with the highest (quartile 4) and lowest (quartile 1) hsCRP concentrations revealed that the adjusted hazard ratios and 95{\%} confidence intervals were 1.50 (1.31-1.72) for all-cause mortality, 1.44 (1.13-1.82) for cardiovascular mortality, and 1.67 (1.23-2.26) for cancer mortality. The associations between high hsCRP concentrations and the risks of all-cause, cardiovascular, and cancer mortality were similar in the men and women (P for interaction > 0.05). Conclusions: Among middle-aged and older individuals, elevated hsCRP concentration could increase the risk of all-cause, cardiovascular, and cancer mortality in men and women.",
author = "Li, {Zhi Hao} and Zhong, {Wen Fang} and Lv, {Yue Bin} and Kraus, {Virginia Byers} and Xiang Gao and Chen, {Pei Liang} and Huang, {Qing Mei} and Ni, {Jin Dong} and Shi, {Xiao Ming} and Chen Mao and Wu, {Xian Bo}",
year = "2019",
month = "11",
day = "5",
doi = "10.1186/s12979-019-0168-5",
language = "English (US)",
volume = "16",
journal = "Immunity and Ageing",
issn = "1742-4933",
publisher = "BioMed Central",
number = "1",

}

Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals. / Li, Zhi Hao; Zhong, Wen Fang; Lv, Yue Bin; Kraus, Virginia Byers; Gao, Xiang; Chen, Pei Liang; Huang, Qing Mei; Ni, Jin Dong; Shi, Xiao Ming; Mao, Chen; Wu, Xian Bo.

In: Immunity and Ageing, Vol. 16, No. 1, 28, 05.11.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Associations of plasma high-sensitivity C-reactive protein concentrations with all-cause and cause-specific mortality among middle-aged and elderly individuals

AU - Li, Zhi Hao

AU - Zhong, Wen Fang

AU - Lv, Yue Bin

AU - Kraus, Virginia Byers

AU - Gao, Xiang

AU - Chen, Pei Liang

AU - Huang, Qing Mei

AU - Ni, Jin Dong

AU - Shi, Xiao Ming

AU - Mao, Chen

AU - Wu, Xian Bo

PY - 2019/11/5

Y1 - 2019/11/5

N2 - Background: The association of high-sensitivity C-reactive protein (hsCRP) with mortality is controversial. We aimed to investigate the associations of hsCRP concentrations with the risks of all-cause and cause-specific mortality and identify potential modifying factors affecting these associations among middle-aged and elderly individuals. Methods: This community-based prospective cohort study included 14,220 participants aged 50+ years (mean age: 64.9 years) from the Health and Retirement Study. Cox proportional hazard models were employed to estimate the associations between the hsCRP concentrations and the risk of all-cause and cause-specific mortality with adjustment for sociodemographic and lifestyle factors, self-reported medical history, and other potential confounders. Results: In total, 1730 all-cause deaths were recorded, including 725 cardiovascular- and 417 cancer-related deaths, after an 80,572 person-year follow-up (median: 6.4 years; range: 3.6-8.1 years). The comparisons of the groups with the highest (quartile 4) and lowest (quartile 1) hsCRP concentrations revealed that the adjusted hazard ratios and 95% confidence intervals were 1.50 (1.31-1.72) for all-cause mortality, 1.44 (1.13-1.82) for cardiovascular mortality, and 1.67 (1.23-2.26) for cancer mortality. The associations between high hsCRP concentrations and the risks of all-cause, cardiovascular, and cancer mortality were similar in the men and women (P for interaction > 0.05). Conclusions: Among middle-aged and older individuals, elevated hsCRP concentration could increase the risk of all-cause, cardiovascular, and cancer mortality in men and women.

AB - Background: The association of high-sensitivity C-reactive protein (hsCRP) with mortality is controversial. We aimed to investigate the associations of hsCRP concentrations with the risks of all-cause and cause-specific mortality and identify potential modifying factors affecting these associations among middle-aged and elderly individuals. Methods: This community-based prospective cohort study included 14,220 participants aged 50+ years (mean age: 64.9 years) from the Health and Retirement Study. Cox proportional hazard models were employed to estimate the associations between the hsCRP concentrations and the risk of all-cause and cause-specific mortality with adjustment for sociodemographic and lifestyle factors, self-reported medical history, and other potential confounders. Results: In total, 1730 all-cause deaths were recorded, including 725 cardiovascular- and 417 cancer-related deaths, after an 80,572 person-year follow-up (median: 6.4 years; range: 3.6-8.1 years). The comparisons of the groups with the highest (quartile 4) and lowest (quartile 1) hsCRP concentrations revealed that the adjusted hazard ratios and 95% confidence intervals were 1.50 (1.31-1.72) for all-cause mortality, 1.44 (1.13-1.82) for cardiovascular mortality, and 1.67 (1.23-2.26) for cancer mortality. The associations between high hsCRP concentrations and the risks of all-cause, cardiovascular, and cancer mortality were similar in the men and women (P for interaction > 0.05). Conclusions: Among middle-aged and older individuals, elevated hsCRP concentration could increase the risk of all-cause, cardiovascular, and cancer mortality in men and women.

UR - http://www.scopus.com/inward/record.url?scp=85074708723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074708723&partnerID=8YFLogxK

U2 - 10.1186/s12979-019-0168-5

DO - 10.1186/s12979-019-0168-5

M3 - Article

AN - SCOPUS:85074708723

VL - 16

JO - Immunity and Ageing

JF - Immunity and Ageing

SN - 1742-4933

IS - 1

M1 - 28

ER -